RPH3A
RPH3A (rabphilin 3A, also known as rabphilin, exophilin-1 and KIAA0985) is a synaptic vesicle-associated protein that acts in the docking and fusion steps of regulated exocytosis. It is an effector of the small G protein RAB3A and contributes to neurotransmitter release. Browse Assay Genie's current range of RPH3A research reagents below, or read on for the biology behind the target.
RPH3A plays an essential role in the docking and fusion steps of regulated exocytosis. At the presynaptic level, the protein is recruited by RAB3A to the synaptic vesicle membrane in a GTP-dependent manner. There it modulates synaptic vesicle trafficking and calcium-triggered neurotransmitter release. NCBI Gene describes the encoded protein as an effector for RAB3A, a small G protein that acts in the late stages of neurotransmitter exocytosis.
RPH3A also has a role on the post-synaptic side. In the post-synaptic compartment it forms a ternary complex with GRIN2A and DLG4 and regulates NMDA receptor stability. It has also been linked to the exocytosis of the hormone arginine vasopressin, which indicates a function beyond classical synaptic transmission. UniProt records the protein in the synaptic vesicle membrane of secretory vesicles, in dendritic spines and at the postsynaptic cell membrane.
The human RPH3A gene belongs to the HGNC gene group of synaptotagmin like tandem C2 proteins. Orthologues are annotated in mouse and rat, both named Rph3a. The gene has also been listed as KIAA0985 and, previously, as rabphilin 3A homolog (mouse). The name exophilin-1 is used as an alternative to rabphilin. Studies of the RPH3A protein are relevant to work on vesicle trafficking, neurotransmitter release and NMDA receptor regulation.
RPH3A modulates synaptic vesicle trafficking and is recruited to the vesicle membrane by RAB3A, making it a useful focus for docking and fusion studies.
The protein contributes to calcium-triggered neurotransmitter release, so it is studied in work on how presynaptic terminals control exocytosis.
RPH3A forms a ternary complex with GRIN2A and DLG4 post-synaptically and regulates NMDA receptor stability.
RPH3A has a role in the exocytosis of arginine vasopressin, extending its relevance to regulated secretion outside the synapse.
RPH3A is essential for the docking and fusion steps of regulated exocytosis. Presynaptically, RAB3A recruits it to the synaptic vesicle membrane in a GTP-dependent manner, where it modulates vesicle trafficking and calcium-triggered neurotransmitter release. Post-synaptically, it helps regulate NMDA receptor stability.
RPH3A stands for rabphilin 3A. It is also called rabphilin and exophilin-1, and the gene has been listed as KIAA0985. A previous HGNC name was rabphilin 3A homolog (mouse). UniProt lists the protein as Rabphilin-3A.
Yes. Mouse and rat orthologues are both annotated as Rph3a. In the HGNC classification, the human gene sits in the synaptotagmin like tandem C2 proteins group. Check the datasheet of any product for its validated reactivity.
RAB3A, NMDA receptor partners and other proteins in synaptic vesicle exocytosis and neurotransmitter release.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9Y2J0; product specifications from Assay Genie datasheets.